Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable (III)-67-2 (IGHVIII-67-2) is a genomic segment classified as a pseudogene within the immunoglobulin heavy chain variable region locus on chromosome 14q32.33[2][4]. The immunoglobulin heavy chain locus comprises numerous variable (V), diversity (D), and joining (J) segments, which recombine to create functional antigen-binding sites on antibodies, mediating adaptive immunity[1][6]. However, many gene segments in this locus are pseudogenes; they carry sequence similarity to functional immunoglobulin genes but are non-functional due to mutations or deletions, and do not encode protein products. IGHVIII-67-2 falls into this category, meaning it does not contribute to the diversity of antibodies or encode a receptor protein that might serve as a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable (III)-67-2 (IGHVIII-67-2).